Nutritional status and survival in end-stage renal disease patients

Mineral and Electrolyte Metabolism

Volumn 24, Issue 1, 1997, Pages 72-81

  Owen, William F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Albumin C reactive protein; Creatinine; Death risk; Malnutrition; Prealbumin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; PREALBUMIN;

DEATH; HUMAN; KIDNEY FAILURE; MALNUTRITION; NUTRITIONAL STATUS; PREDICTION; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; RISK;

HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITION DISORDERS; NUTRITIONAL STATUS; SURVIVAL RATE;

EID: 12644264300     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057353     Document Type: Review

References (123)

1. Renal Data System: USRDS 1996 Annual Data Report. Bethesda, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1996.
2. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-669.
3. Owen WF, Lew NL, Yan Liu SM, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1101-1106.
4. Parker TF, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994;23:670-680.
5. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 1996; 50(2):550-556.
6. Department of Health and Human Services: 1996: ESRD Core Indicators Project. Baltimore, Md, Health Care Financing Administration, Health Standards and Quality Bureau, 1996.
7. Port FK: End-stage renal disease: Magnitude of the problem, prognosis of future trends and possible solutions. Kidney Int 1995;48(suppl 50):S3-S6.
8. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
9. Lowrie EG, Lew NL: Commonly measured laboratory variables in hemodialysis patients: Relationship among them and to death risk. Sernin Nephrol 1992;12:276-283.
10. Lowrie EG: Chronic dialysis treatment: Clinical outcome and related processes of care. Am J Kidney Dis 1994;24:255-266.
11. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: Markers for survival in dialysis: A seven year prospective study. Am J Kidney Dis 1995;26:209-219.
12. Lowrie EG, Huang WH, Lew NL, Lui Y: The relative contribution of measured variables to death risk among hemodialysis patients; in Friedman E (ed): Death on Hemodialysis: Preventable or Inevitable. Dordrecht, Kluwer, 1994, pp 121-141.
13. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115-119.
14. Cano N, Fernandez JP, Lacombe P, Lankester M, Pascal S, Defayolle M, Labastie J, Saingra S: Statistical selection of nutritional parameters in hemodialyzed patients. Kidney Int 1987 (suppl 22):178-180.
15. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG: Serum albumin in patients on continuous ambulatory peritoneal dialysis - Predictors and correlations with outcome. J Am Soc Nephrol 1993;3:1501-1507.
16. Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome. J Am Soc Nephrol 1996;7:198-207.
17. Acchiardo S, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983 (suppl 24):199-203.
18. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23: 272-282.
19. Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG: The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 1994;24:912-920.
20. Foulks CJ: The effect of intradialytic parenteral nutrition on hospitalization rate and mortality in malnourished hemodialysis patients. J Renal Nutr 1991;1:23-33.
21. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 1994;23: 808-816.
22. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 1982;31:103-110.
23. Keshiviah P, Churchill DN, Thorpe K, Taylor DW: Impact of nutrition on CAPD mortality (abstract). J Am Soc Nephrol 1994;5:494.
24. Chandra RK: Nutrition, immunity, and infection: Present knowledge and future direction. Lancet 1983;i:688-691.
25. Mattem WD, Hak LJ, Lamanna RW, Teasley KM, Laffell MS: Malnutrition, altered immune function, and the risk of infection in maintenance hemodialysis patients. Am J Kidney Dis 1982;1:206-218.
26. Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 1984;39:547-555.
27. Bansal VK, Popli S, Pickering J, Ing T, Vertuno LL, Hano JE: Protein-calorie malnutrition and cutaneous anergy in hemodialysis maintained patients. Am J Clin Nutr 1980;33:1608-1611.
28. Acchiardo SR, Moore LW, Burk L: Morbidity and mortality in hemodialysis patients. ASAIO Trans 1990;36:M148-M151.
29. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 1992;19: 214-234.
30. Emerson TE: Unique features of albumin: A brief review. Crit Care Med 1989;17:690-694.
31. Yalcin AS, Yurtkin M, Dilek K, Kilinc A, Taga Y, Emerk K: The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients. Clin Chim Acta 1989;185:109-112.
32. Stampfer MJ, Hennekens CH, Manson JAE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
33. Rimm EB, Stampfer MJ, Aschiero A, Giovannuci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
34. 2 and vitamin E in longterm hemodialysis. J Am Med Assoc 1971;217:699.
35. Stein G, Sperschhneider H, Koppe S: Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 1985;3:52-62.
36. Ritz E, Vallance P, Nowicki M: The effect of malnutrition on cardiovascular mortality in hemodialysis patients: Is L-arginine the answer? Nephrol Dial Transplant 1994;9:129-130.
37. Bergstrom J, Alvestrand A, Furst P: Plasma and muscle free amino acids in maintenance hemodialysis patients without malnutrition. Kidney Int 1990;38:108-114.
38. Phillips A, Shaper AG, Whincup PH: Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1990;i:1434-1436.
39. Herrman FR, Safran C, Levkoff SE, Minaker KL: Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992;152:125-130.
40. Darnes B, Ducimetiere P: Serum albumin and mortality. Lancet 1990;i:350-351.
41. Chumlea WC, Guo SS, Vella B: Assessment of protein-calorie nutrition; in Kopple J, Massry S (eds): Nutritional Management of Renal Disease. Baltimore, Williams & Wilkins, 1997, pp 203-228.
42. Rothchild MA: Albumin synthesis. N Engl J Med 1972;286:748-757.
43. Klein S: The myth of serum albumin as a measure of nutritional status. Gastroenterology 1990;99:1845-1846.
44. Lenter C (ed): Geigy Scientific Tables. Vol 3: Physical Chemistry, Composition of Blood, Hematology, Somatometric Data. Basel, Ciba-Geigy, 1984.
45. Tullis JL: Albumin 2: Guidelines for clinical use. J Am Med Assoc 1977;237:460-463.
46. Steel DM, Whitehead AS: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-88.
47. Dinarello CA: Mechanisms of disease: Interleukin 1 and the pathogenesis of the acute phase response. N Engl J Med 1984;311:1413-1418.
48. Castell JV, Andus T, Kunz D, Heinrich PC: Interleukin-6, the major regulator of acutephase protein synthesis in man and rat. Ann NY Acad Sci 1989;57:87-99.
49. Kurshner I: The phenomenon of the acute phase response. Ann NY Acad Sci 1982;389: 3948.
50. Stahl WM: Acute phase protein response to tissue injury. Crit Care Med 1987;15:545-550.
51. Ballmer PE, Ballmer-Hofer K, Repond F, Kohler H, Studer H: Acute suppression of albumin synthesis in systemic inflammatory disease: An individually graded response of rat hepatocytes. J Histochem Cytochem 1992;40: 201-206.
52. Beisel WR: Herman Award Lecture, 1995: Infection-induced malnutrition - From cholera to cytokines. Am J Clin Nutr 1995;62:813-819.
53. Langstein HN, Norton JA: Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991;5:103-122.
54. Espat NJ, Copeland EM, Moldawer LL: Tumor necrosis factor and cachexia: A current perspective. Surg Oncol 1994;3:255-262.
55. Klasing KC: Nutritional aspects of leukocytic cytokines. J Nutr 1988;118:1436-1446.
56. Grimble RF: Cytokines: Their relevance to nutrition. Eur J Clin Nutr 1989;43:217-230.
57. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW: Infusion of tumor necrosis factor: Cachectin promotes muscle catabolism in the rat. J Clin Invest 1989;83:1614-1622.
58. Cheung AK: Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990;1:150-161.
59. Guttierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990;38:487-494.
60. Guttierrez A, Bergstrom J, Alvestrand A: Protein catabolism in sham-hemodialysis: The effect of different membranes. Clin Nephrol 1992;38:20-29.
61. Hakim RM, Wingard RL, Ikizler TA, Parker RA, Vanholder R, Husni L, Parker TF: Effects of biocompatibility on nutritional status in chronic hemodialysis patients. J Am Soc Nephrol 1994;5:541.
62. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulfone dialyzers. Kidney Int 1994; 47:573-578.
63. Ikizler TA, Falkoll PJ, Parker TA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-837.
64. Kaysen GA, Rathorne V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
65. Young GA, Brownjohn AM, Parsons FM: Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephron 1987;45: 196-201.
66. Dulaney JT, Hatch FE: Peritoneal dialysis and loss of proteins: A review. Kidney Int 1984;26-253-262.
67. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 1981;19:593-602.
68. Kaysen GA, Schoenfeldt PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984;25: 107-114.
69. Blumenkrantz MJ, Salusky IB, Schmidt RW: Managing the nutritional concerns of the patient undergoing peritoneal dialysis; in Nolph KD (ed): Peritoneal Dialysis. Boston, Martinus Nijhoff, 1985, pp 345-401.
70. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 1993;265:E230-235.
71. May RC, Hara Y, Kelly RA, Block KP, Buse M, Mitch WE: Branched-chain amino acid metabolism in rat muscle: Abnormal regulation in acidosis. Am J Physiol 1987;252:E712-E718.
72. Lim VS, Bier DM, Flanagan MJ, Sum-Ping ST: Acidosis increased amino acid oxidation in chronic renal (CRF) patients. J Am Soc Nephrol 1993;4:252.
73. Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, Bailey JL, Goldberg AL: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteosomes. J Clin Invest 1994; 93(5):2127-2133.
74. Tabachinik BG, Fidell LS: Using Multivariate Statistics, ed 2. New York, Harper Collins, 1989.
75. Levey A, Perrone R, Madias N: Serum creatinine and renal function. Annu Rev Med 1988; 39:465-490.
76. Schoenfeld PY, Henry RR, Laird NM, Rose DM: Assessment of nutritional status of the National Cooperative Dialysis Study population. Kidney Int 1983;23:S80-S88.
77. Thunberg BJ, Swamy AP, Cestero RVM: Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 1981;34:2005-2112.
78. Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 1981;37:547-555.
79. Markmann P: Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 1988;29:75-78.
80. Bilbrey GL, Cohen TL: Identification and treatment of protein calorie malnutrition in chronic hemodialysis patients. Dial Transplant 1989;18:669-700.
81. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vccchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 1991;27:462-471.
82. Pollock CA, Allen BJ, Warden RA, Caterson RJ, Blagojevic N, Cocksedge B, Mahony JF, Waugh DA, Ibels LS: Total body nitrogen by neutron activation in maintenance dialysis.
83. Winkler MF, Gerrior SA, Pomp A, Albina JE: Use of retinol-binding protein and prealbumin as indicators of the response to nutrition therapy. J Am Diet Assoc 1989;89:684-687.
84. Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, Avram MM: Prealbumin and lipoprotein (a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis 1993;22:215-225.
85. Ooi BS, Darocy AF, Pollock VE: Serum transferrin levels in chronic renal failure. Nephron 1972;9:200-207.
86. Miller D, Levine S, D'Elia J, Bistrian B: Nutritional status of diabetic and nondiabetic patients after renal transplantation. Am J Clin Nutr 1986;4:66-69.
87. Feinstein E, Kopple J: Severe wasting and malnutrition in a patient undergoing maintenance dialysis. Am J Nephrol 1985;5:398-405.
88. Doube A: Nutritional status in dialysis patients. NZ Med J 1985;98:794-796.
89. Jacob V, Le Carpentier JE, Salzano S, Naylor V, Wild G, Brown CB, elNahas AM: IGF-I, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr 1990;52:39-44.
90. Talemaitoga AS, Sanders BA, Hinton D, Lynn KL: Nutritional status of home hemodialysis patients. Aust NZ J Med 1989;19:303-309.
91. Barany P, Pettersson E, Ahlberg M, Hultman E, Bergstrom J: Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin. Clin Nephrol 1991;35:270-279.
92. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Periton Dial Int 1994;14:121-126.
93. Kopple JD, Chumlea WC, Gassman JJ, Hollinger DL, Maroni BJ, Merrill D, Scherch LK, Schulman G, Zimmer GS: Relationship between GFR and nutritional status: Results from the MDRD study. J Am Soc Nephrol 1994;5:325.
94. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-1181.
95. Harter HR: Review of findings from the National Cooperative Dialysis Study and recommendations. Kidney Int 1983;23:S107-S112.
96. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534.
97. Parker TF, Laird NM, Lowrie EG: Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int 1983;23:S42-S49.
98. Renal Physicians Association Working Committee on Clinical Practice Guidelines. Clinical Practice Guideline on Adequacy of Hemodialysis. Clinical Practice Guideline, Number 1. Washington, Dec 1993.
99. Raja RM, Ijelu G, Goldstein M: Influence of Kt/V and protein catabolic rate on hemodialysis morbidity: A long term study. ASAIO J 1992;38:M179-M180.
100. Lindsay RM, Spanner E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 1989;13:382-389.
101. Lindsay RM, Spanner E, Heidenheim P, Kortas C, Blake P: PCR, Kt/V and membrane. Kidney Int 1993;43(suppl 41):S268-S273.
102. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfson M, Humphreys MH: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978;14:491-500.
103. Lowrie EG, Laird NM, Henry RR: Protocol for the National Cooperative Dialysis Study. Kidney Int 1983;23(suppl):S11-S18.
104. Hakim RA, Breyer J, Ismali N, Schulman G: Effects of dose of hemodialysis on morbidity and mortality. Am J Kidney Dis 1994;23: 661-669.
105. Bergstrom J, Mamoun AH, Anderstam B, Soderstein P: Middle molecules isolated from uremic ultrafiltrate and normal urine induce dose-dependent inhibition of appetite in the rat. J Am Soc Nephrol 1994;5:488.
106. Bergstrom J, Lindholm B: Nutrition and adequacy of dialysis: How do hemodialysis and CAPD compare? Kidney Int 1993;43(suppl): S39-S50.
107. Bergstrom J: Nutrition and mortality in hemodialysis. J Am Soc Nephrol 1995;6:1329-1341.
108. Renal Data System: USRDS 1994 Annual Data Report. Bethesda, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1994.
109. Degoulet P, Legrain M, Reach I: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 1982;31:103-110.
110. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23:272-282.
111. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: Causes of death of dialysis patients: Racial and gender differences. J Am Soc Nephrol 1994;5:1231-1242.
112. Lowrie EG, Lew NL, Huang WH: Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int 1992;42(suppl):22-31.
113. Bergström J, Heimbürger O, Lindholm B, Qureshi AR: Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis patients (abstract). J Am Soc Nephrol 1995;6: 573.
114. Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimond J: Urea kinetic analysis and clinical outcome on CAPD: A five year longitudinal study. Adv Periton Dial 1991;6:181-185.
115. Blake PG, Sombolos K, Abraham G, Weissgarten J, Pemberton R, Chu GL, Oreopoulos DG: Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991;39:700-706.
116. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG: Serum albumin in patients on continuous peritoneal dialysis - Predictors and correlations with outcomes. J Am Soc Nephrol 1993;3:1501-1507.
117. Gamba G, Meiia JL, Saldivar S, Pena JC, Correa-Rotter R: Death risk in CAPD patients. Nephron 1993;65:23-27.
118. Avram MM, Goldwasser P, Erroa M, Fein PA: Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 1994;23:91-98.
119. Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA: Serum albumin: A marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis 1993; 21:26-30.
120. Spiegel DM, Breyer JA: Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients. Am J Kidney Dis 1994;23: 283-285.
121. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Periton Dial Int 1994;14:121-126.
122. Keshaviah P, Churchill DN, Thorpe K, Taylor DW: Impact of nutrition on CAPD mortality (abstract). J Am Soc Nephrol 1994;5: 494.
123. Chertow G, Ling J, Lew NL, Lazarus JM, Lowrie EG: The effect of intradialytic parenteral nutrition on survival in hemodialysis patients. J Am Soc Nephrol 1994;24:912-920.